Listed

Interlink Electronics Inc: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 9, 2018 and accepted by EDGAR at Aug 9, 2018, 06:12 ET.

Share

Management's discussion and analysis

As filed, 36,697 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements concerning the following:

  • our future financial and operating results;
  • our business strategy;
  • our intentions, expectations and beliefs regarding anticipated growth, market penetration and trends in our business;
  • our dependence on growth in our customers’ businesses;
  • the effects of market conditions on our stock price and operating results;
  • our ability to maintain our competitive technological advantages against competitors in our industry;
  • our ability to timely and effectively adapt our existing technology and have our technology solutions gain market acceptance;
  • our ability to introduce new products and bring them to market in a timely manner;
  • our ability to maintain, protect and enhance our intellectual property;
  • the effects of increased competition in our market and our ability to compete effectively;
  • costs associated with defending intellectual property infringement and other claims;
  • our expectations concerning our relationships with customers and other third parties;
  • our expectations concerning relationships between our customers and their manufacturers;
  • the attraction and retention of qualified employees and key personnel;
  • future acquisitions of or investments in complementary companies or technologies; and
  • our ability to comply with evolving legal standards and regulations, particularly concerning requirements for being a public company and United States export regulations.

These forward-looking statements speak only as of the date of this Form 10-Q and are subject to uncertainties, assumptions and business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking statements as a result of the factors set forth below in Part II, Item 1A, “Risk Factors,” and in our other reports filed with the Securities and Exchange Commission. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Form 10-Q may not occur, and actual results could differ materially and adversely from those anticipated or implied in our forward-looking statements.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Form 10-Q to conform these statements to actual results or to changes in our expectations, except as required by law.

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect.

Overview and Outlook

Overview

Interlink Electronics, Inc. (“we”, “us”, “our”, “Interlink” or the “Company”) designs, develops, manufactures and sells a range of force-sensing technologies that incorporate our proprietary materials technology, firmware and software into a portfolio of standard products and custom solutions. These include sensor components, subassemblies, modules and products that support effective, efficient cursor control and novel three-dimensional user inputs. Our Human Machine Interface (“HMI”) technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical. The application of our HMI technology platforms includes vehicle entry, vehicle multi-media control interface, rugged touch controls, presence detection, collision detection, speed and torque controls, biological monitoring and others.

Interlink has been a leader in the printed electronics industry for over 30 years with the commercialization of our patented Force Sensing Resistor (“FSR®”) technology that has enabled rugged and reliable HMI solutions. Our solutions have focused on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world’s top electronics manufacturers.

We sell our products globally to a diverse array of customers that include the Fortune 500 as well as start-ups, design houses, original design manufacturers, OEMs and universities. Our technology has been deployed in the consumer electronics, industrial automation, automotive and medical markets. Our global presence in the United States, China, Hong Kong, Singapore and Japan, allows us to provide local sales and engineering support services to our existing and future customers. Our products are manufactured by our wholly-owned subsidiary in a state-of-the-art facility in Shenzhen, China. We also maintain engineering, assembly and prototyping capabilities in Simi Valley, California. We control 100% of the manufacturing and shipping process which enables us to respond quickly to customer product demand and design requirements.

Over the next three years, we anticipate investing significantly in the expansion of our technology platforms through our own internal development to ensure we provide the market with leading-edge HMI solutions that are seamless to deploy and preform flawlessly. We are dramatically growing our R&D organization in Singapore to ensure we have the right team to launch our current designs and develop new product offerings that will meet the market’s growing demand for touch technology. Our Singapore location allows us to take advantage of the abundance of engineering talent for future new product development. We are also exploring potential strategic relationships with Singapore-based companies and technology institutes that will support our growth initiatives.

Outlook

We follow market research conducted by IDTechEx and other independent parties in the printed, flexible electronics industry. Market research indicates that the sensor portion of the printed electronics market is growing rapidly. We maintain our focus on developing solutions around scalable sensor and product architectures and emerging applications in order to capitalize on this growth. We believe there are significant innovation opportunities for sensors with novel functions and form factors, which is why we have invested heavily in R&D to develop disruptive technology platforms and a robust patent portfolio. We expect to accelerate such investments over the next 12 – 36 months as we continue to build out our R&D engineering center in Singapore.

The industrial markets we serve (automotive, medical, rugged computing, industrial tools and equipment, among others) face challenges driven by product innovation, changes in talent requirements, and disruptions in energy markets. Such challenges present an opportunity for us to emerge as a solution provider for these markets. These opportunities include: new technologies such as industrial Internet-of-Things (“IoT”), robotics and advanced manufacturing, and the skills and solutions needed to manage embedded technology and data analytics. If capitalized and managed correctly, these innovations can support step changes in productivity by allowing companies to more actively monitor and optimize plant, asset, and supply chain performance.

The consumer market faces an unprecedented confluence of changes such as declining brand loyalty, rapidly evolving technologies, changing demographics and consumer preferences, and economic uncertainty. The opportunities for us are to provide solutions to help consumer products companies keep up with the frantic pace of innovation to maintain performance of existing categories while also building the breakthrough new businesses of the future. The advent of smarter products (e.g., products with embedded sensor technologies) provides an opportunity for us to deliver unique solutions to build and nurture breakthrough innovation.

Overall, our customers tend to be market leaders, and have been stable enough to manage their businesses through any challenging market cycle. In spite of decreased sales resulting from the loss a significant customer platform, we are very pleased with our performance in the three and six months ended June 30, 2018. We are confident that our leadership position in providing HMI solutions remains strong.

We remain committed to our strategy to create shareholder value through earnings growth and balanced capital allocation, including disciplined investments for organic growth and innovation and strategic bolt-on acquisitions. In connection with our growth strategy, we will continue to evaluate potential acquisitions in 2018; however, the effect of such acquisitions cannot be predicted and therefore is not reflected in this outlook.

Critical Accounting Policies and Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events that affect the amounts reported in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements. Actual results could differ significantly from those estimates. We base our estimates on historical experience and on various other assumptions that we believe are reasonable in the circumstances. We regularly discuss with our audit committee the basis of our estimates. These estimates could change under different assumptions or conditions.

We believe that our critical accounting policies and estimates, as described in our annual Report on Form 10-K for the year ended December 31, 2017, are most important to the portrayal of our financial condition and results of operations and require management’s most difficult, subjective and complex judgments. There have been no significant changes to these polices during the six months ended June 30, 2018.

Impact of Recent Accounting Pronouncements

For information with respect to recent accounting pronouncements and the impact of these pronouncements see “Note 1 - The Company and its Significant Accounting Policies – Recently Adopted Accounting Pronouncements” and “Recently Issued Accounting Pronouncements (Not Yet Adopted)” in the accompanying notes to the unaudited condensed consolidated financial statements.

Results of Operations

The following table sets forth certain unaudited condensed consolidated statements of income data for the periods indicated. The percentages in the table are based on net revenues.

(in thousands, except percentages)

(in thousands, except percentages)

Three months ended June 30, 2018 $% 2017 $% Six months ended June 30, 2018 $% 2017 $%
Revenue, net $2,683 100.0% $3,264 100.0% $5,256 100.0% $6,148 100.0%
Cost of revenue 1,135 42.3% 1,203 36.9% 2,297 43.7% 2,351 38.2%
Gross profit 1,548 57.7% 2,061 63.1% 2,959 56.3% 3,797 61.8%
Operating expenses:
Engineering, research and development 237 8.8% 157 4.8% 461 8.8% 335 5.4%
Selling, general and administrative 881 32.8% 1,065 32.6% 1,849 35.1% 2,092 34.1%
Total operating expenses 1,118 41.6% 1,222 37.4% 2,310 43.9% 2,427 39.5%
Income from operations 430 16.1% 839 25.7% 649 12.4% 1,370 22.3%
Other income (expense):
Other income (expense), net 62 2.3% (2) (0.1)% 16 0.3% 17 0.3%
Income before income tax expense 492 18.4% 837 25.6% 665 12.7% 1,387 22.6%
Income tax expense 133 5.0% 288 8.8% 188 3.6% 474 7.7%
Net income $359 13.4% $549 16.8% $477 9.1% $913 14.9%
Other comprehensive income, net of tax:
Foreign currency translation adjustments (112) (4.2)% 25 0.8% (27) (0.5)% 36 0.5%
Comprehensive income $247 9.2% $574 17.6% $450 8.6% $949 15.4%

Results of Operations for the three months ended June 30, 2018, as compared to the three months ended June 30, 2017

Revenue, net by Market is as follows:

(in thousands, except percentages)

Three months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Automotive $119 4.4% $1,016 31.1% $(897) (88.3)%
Industrial 615 22.9% 475 14.5% 140 29.6%
Medical 359 13.4% 350 10.7% 9 2.7%
Consumer 486 18.1% 486 14.9% (0) (0.0)%
Standard 1,104 41.2% 937 28.8% 167 17.8%
Revenue, net $2,683 100.0% $3,264 100.0% $(581) (17.8)%

We sell our custom products into the following markets: automotive, industrial, medical and consumer. We sell our standard products in many different markets which are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often have much longer product life-cycles. Automotive, industrial, and medical products generally have longer design and life-cycles than consumer products. We currently have products with life-cycles that have exceeded twenty years and are ongoing.

The decrease in net revenues was driven by a major customer in the automotive market making a design change to their product that eliminated the need for our solution. This decrease was partially offset by increased sales of our custom products in the industrial and medical markets. We also had an increase in sales of our standard products. Other than the automotive market, growth in our custom product sales was driven by increased sales to our current customers for use in ongoing product lines. In all of our custom product markets, some of our larger customers purchase in bulk quantities and absorption of these products can straddle several financial reporting periods. The timing of orders from our customers is not always predictable and can be concentrated in varying periods during the year to coincide with their project and building plans.

Some of our more recent custom product success for new product lines in the medical market has been in the pipeline as part of a long design cycle and revenues are just starting to be realized in 2018. In July 2018, subsequent to quarter end, the Company received purchase orders of $880,000 from an existing prestigious medical customer. This order is for deliveries from October 2018 to June 2019. However, as these revenues materialize, revenues from current product lines that reach the end of their life cycle will likely offset some of this expected growth in 2018. Overall. we expect revenues to be lower in the second half of 2018 until we are able to fully replace the automotive revenue.

(in thousands, except percentages)

Three months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Cost of revenue $1,135 42.3% $1,203 36.9% $(68) (5.7)%

Our cost of revenue is impacted by various factors including product mix, volume, material costs, manufacturing efficiencies, facilities costs, compensation costs and any provisions for excess and obsolete inventories. Cost of revenues decreased compared with the prior year consistent with the decrease in revenues, particularly in the automotive market. Cost of revenues increased as a percentage of revenues for the same reason, including less revenue to cover fixed costs and production overhead costs.

(in thousands, except percentages)

Three months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Engineering, research and development $237 8.8% $157 4.8% $80 51.0%

Engineering and R&D expenses consist primarily of compensation expenses for employees engaged in research, design and development activities. Our R&D team focuses both on internal design development, as well as design development aimed at addressing customer design challenges, in order to develop our HMI solutions.

Our engineering and R&D costs increased as compared with the same period in the prior year primarily due to continued investments in our Singapore R&D center and an increase in our engineering and R&D staffing worldwide in order to enhance our technology and product offerings. We will continue to substantially grow the global R&D center in

Singapore over the next three years, including expanding our R&D team, expanding the size of the facility, and investing in additional tools and equipment.

(in thousands, except percentages)

Three months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Selling, general and administrative $881 32.8% $1,065 32.6% $(184) (17.3)%

Selling, general and administrative expenses (“SG&A”) consist primarily of compensation expenses, legal and other professional fees, facilities expenses and communication expenses. SG&A expenses decreased as compared with the same period in the prior year driven by internal efficiencies gained during a period of lower revenue, and reduced reliance of third party consultants and professional service providers.

(in thousands, except percentages)

Three months ended June 30, 2018 Amount % of Pre-tax Income 2017 Amount % of Pre-tax Income Change % Change
Income tax expense (benefit) $133 27.0% $288 34.4% $(155) (53.8)%

Tax expense reflects statutory tax rates in the jurisdictions that we operate adjusted for normal book/tax differences. Tax expense for the three months ended June 30, 2018 was lower primarily as a result of the enactment of the 2017 Tax Cut and Jobs Act (TCJA), which was signed into law on December 22, 2017. The TCJA significantly reforms the Internal Revenue Code of 1986 (as amended) and includes, among other things, changes to U.S. Federal tax rates, significant additional limitations on the deductibility of interest, immediate expensing of certain capital expenditures, migration from a “worldwide” system of taxation to a territorial system and the modification or repeal of many business deductions and credits.

Our effective tax rate is directly affected by the relative proportions of revenue and income before taxes in the jurisdictions in which we operate. Based on the expected mix of domestic and foreign earnings, we anticipate our effective tax rate to remain lower than prior periods primarily due to a significant portion of our earnings originating in lower rate foreign jurisdictions, and the reduction of the U.S. federal tax rates under the TCJA. Discrete tax events may cause our effective rate to fluctuate on a quarterly basis. Certain events, including, for example, acquisitions and other business changes, which are difficult to predict, may also cause our effective tax rate to fluctuate. We are subject to changing tax laws, regulations, and interpretations in multiple jurisdictions. Continued corporate tax reform continues to be a priority in the U.S. and other jurisdictions. Additional changes to the tax system in the U.S. could have significant effects, positive and negative, on our effective tax rate, and on our deferred tax assets and liabilities.

Results of Operations for the six months ended June 30, 2018, as compared to the six months ended June 30, 2017

Revenue, net by Market is as follows:

(in thousands, except percentages)

Six months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Automotive $266 5.1% $1,716 27.9% $(1,450) (84.5)%
Industrial 1,260 24.0% 1,122 18.2% 138 12.3%
Medical 774 14.7% 698 11.4% 76 10.9%
Consumer 934 17.8% 935 15.2% (1) (0.1)%
Standard 2,022 38.5% 1,677 27.3% 345 20.6%
Revenue, net $5,256 100.0% $6,148 100.0% $(892) (14.5)%

We sell our custom products into the following markets: automotive, industrial, medical and consumer. We sell our standard products in many different markets which are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often have much longer product life-cycles. Automotive, industrial, and medical products generally have longer design and life-cycles than consumer products. We currently have products with life-cycles that have exceeded twenty years and are ongoing.

The decrease in net revenues was driven by a major customer in the automotive market making a design change to their product that eliminated the need for our solution. This decrease was partially offset by increased sales of our custom products in the industrial and medical markets. We also had an increase in sales of our standard products. Other than the automotive market, growth in our custom product sales was driven by increased sales to our current customers for use in ongoing product lines. In all of our custom product markets, some of our larger customers purchase in bulk quantities and absorption of these products can straddle several financial reporting periods. The timing of orders from our customers is not always predictable and can be concentrated in varying periods during the year to coincide with their project and building plans.

Some of our more recent custom product success for new product lines in the medical market has been in the pipeline as part of a long design cycle and revenues are just starting to be realized in 2018. In July 2018, subsequent to quarter end, the Company received purchase orders of $880,000 from an existing prestigious medical customer. This order is for deliveries from October 2018 to June 2019. However, as these revenues materialize, revenues from current product lines that reach the end of their life cycle will likely offset some of this expected growth in 2018. Overall, we expect revenues to be lower in the second half of 2018 until we are able to fully replace the automotive revenue.

(in thousands, except percentages)

Six months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Cost of revenue $2,297 43.7% $2,351 38.2% $(54) (2.3)%

Our cost of revenue is impacted by various factors including product mix, volume, material costs, manufacturing efficiencies, facilities costs, compensation costs and any provisions for excess and obsolete inventories. Cost of revenues decreased compared with the prior year consistent with the decrease in revenues, particularly in the automotive market, although additional costs associated with the abrupt loss of the major customer were recognized in the first quarter of 2018. Cost of revenues increased as a percentage of revenues for the same reason, including less revenue to cover fixed costs and production overhead costs.

25

(in thousands, except percentages)

Six months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Engineering, research and development $461 8.8% $335 5.4% $126 37.6%

Engineering and R&D expenses consist primarily of compensation expenses for employees engaged in research, design and development activities. Our R&D team focuses both on internal design development, as well as design development aimed at addressing customer design challenges, in order to develop our HMI solutions.

Our engineering and R&D costs increased as compared with the same period in the prior year primarily due to continued investments in our Singapore R&D center and an increase in our engineering and R&D staffing worldwide in order to enhance our technology and product offerings. We will continue to substantially grow the global R&D center in Singapore over the next three years, including expanding our R&D team, expanding the size of the facility, and investing in additional tools and equipment.

(in thousands, except percentages)

Six months ended June 30, 2018 Amount % of Net Revenue 2017 Amount % of Net Revenue Change % Change
Selling, general and administrative $1,849 35.1% $2,092 34.1% $(243) (11.6)%

Selling, general and administrative expenses consist primarily of compensation expenses, legal and other professional fees, facilities expenses and communication expenses. SG&A expenses decreased slightly as compared with the same period in the prior year driven by internal efficiencies gained during a period of lower revenue, and reduced reliance of third party consultants and professional service providers.

(in thousands, except percentages)

Six months ended June 30, 2018 Amount % of Pre-tax Income 2017 Amount % of Pre-tax Income Change % Change
Income tax expense $188 28.3% $474 34.2% $(286) N/A%

Tax expense reflects statutory tax rates in the jurisdictions that we operate adjusted for normal book/tax differences. Tax expense for the three months ended June 30, 2018 was lower primarily as a result of the enactment of the 2017 Tax Cut and Jobs Act (TCJA), which was signed into law on December 22, 2017. The TCJA significantly reforms the Internal Revenue Code of 1986 (as amended) and includes, among other things, changes to U.S. Federal tax rates, significant additional limitations on the deductibility of interest, immediate expensing of certain capital expenditures, migration from a “worldwide” system of taxation to a territorial system and the modification or repeal of many business deductions and credits.

Our effective tax rate is directly affected by the relative proportions of revenue and income before taxes in the jurisdictions in which we operate. Based on the expected mix of domestic and foreign earnings, we anticipate our effective tax rate to remain lower than prior periods primarily due to a significant portion of our earnings originating in lower rate foreign jurisdictions, and the reduction of the U.S. federal tax rates under the TCJA. Discrete tax events may cause our effective rate to fluctuate on a quarterly basis. Certain events, including, for example, acquisitions and other business changes, which are difficult to predict, may also cause our effective tax rate to fluctuate. We are subject to changing tax laws, regulations, and interpretations in multiple jurisdictions. Continued corporate tax reform continues to be a priority in the U.S. and other jurisdictions. Additional changes to the tax system in the U.S. could have significant effects, positive and negative, on our effective tax rate, and on our deferred tax assets and liabilities.

Liquidity and Capital Resources

Cash requirements for working capital and capital expenditures have been funded from cash balances on hand and cash generated from operations. As of June 30, 2018, we had cash and cash equivalents of $6.0 million, working capital of $7.6 million and no indebtedness. Cash and cash equivalents consist of cash and money market funds. We did not have any short-term or long-term investments as of June 30, 2018. Of the $6.0 million of cash balances on hand, $2.3 million was held by foreign subsidiaries. If these funds are needed for our operations in the U.S., we have several methods to repatriate without significant tax effects, including repayment of intercompany loans or distributions of previously taxed income. Other distributions may require us to incur U.S. or foreign taxes to repatriate these funds. However, our intent is to permanently reinvest these funds outside the U.S. and our current plans do not demonstrate a need to repatriate cash to fund our U.S. operations.

We believe that our existing cash and cash equivalents balance will be sufficient to maintain our operations considering our current financial condition, obligations, and other expected cash flows for at least the next twelve months following the date these condensed consolidated financial statements were available for issuance. We are proactively pursuing acquisition opportunities. It is possible our cash requirements for one or more acquisition opportunities could exceed our cash balance at the time of closing. If we require additional cash, we may attempt to raise additional capital through equity, equity-linked or debt financing arrangements. If we raise additional funds by issuing equity or equity-linked securities, the ownership of our existing stockholders will be diluted. If we raise additional financing by the incurrence of indebtedness, we will be subject to fixed payment obligations and could also be subject to restrictive covenants, such as limitations on our ability to incur additional debt, and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to raise additional needed funds, we may also take measures to reduce expenses to offset any shortfall.

We have a Form S-3 universal shelf registration statement on file with the SEC. The universal shelf registration statement on Form S-3 permits us to sell, in one or more public offerings, shares of our common stock, shares of preferred stock or debt securities, or any combination of such securities and warrants to purchase securities, for proceeds in an aggregate amount of up to $35.0 million, subject to limitations on the amount of securities we may sell in any twelve-month period. As of June 30, 2018, we have not issued any securities pursuant to the Form S-3. The Form S-3 will expire in November 2020.

There can be no assurances that we will be able to raise additional needed capital on acceptable terms or at all, and the failure to do so could adversely affect our ability to achieve our business objectives. In addition, if our future operating performance is below our expectations, our liquidity and ability to operate our business could be adversely affected.

Cash Flow Analysis

Our cash flows from operating, investing and financing activities are summarized as follows:

(in thousands)

Six months ended June 30, 2018 2017
Net cash provided by operating activities $1,190 $949
Net cash used in investing activities $(2,997) $(60)
Net cash provided by financing activities $6 $34

Net Cash Provided by Operating Activities

For the six months ended June 30, 2018, the $1,190 thousand in net cash provided by operating activities was primarily attributable to net income of $477 thousand, adjusted for non-cash charges of $124 thousand. The net increase in cash due to changes in operating assets and liabilities of $589 thousand was primarily due to payments and shipments during the period.

For the six months ended June 30, 2017, the $949 thousand in net cash provided by operating activities was primarily attributable to net income of $913 thousand, adjusted for non-cash charges of $136 thousand. The net decrease in cash due to changes in operating assets and liabilities of $100 thousand was primarily due to the timing of shipments and payments during the period.

Net Cash Used in Investing Activities

Net cash used in investing activities was $2,997 thousand for the six months ended June 30, 2018, compared to $60 thousand for the six months ended June 30, 2017. The increase is primarily related to share repurchases of $2,764 thousand plus additional expenditures for leasehold improvements and equipment for the expansion of our global R&D center in Singapore.

Stock Repurchases

In December 2017, our Board of Directors authorized a new program for the repurchase of up to $1 million of our outstanding common shares. This program authorization will expire in December 2018. Pursuant to this program, on January 17, 2018, we repurchased 34,010 common shares at a purchase price of $4.75 per share from an unrelated shareholder in a private transaction. The repurchased shares were immediately retired and restored to the status of authorized and unissued shares.

Separate from and in addition to the $1 million repurchase program, on June 22, 2018, we repurchased 867,681 shares of our common stock at a purchase price of $3.00 per share from an existing stockholder in a private transaction approved by our Board of Directors. The repurchased shares were immediately retired and restored to the status of authorized and unissued shares.

At June 30, 2018, we had 6,478,797 shares of common stock issued and outstanding.

Off-Balance Sheet Arrangements

At June 30, 2018 and December 31, 2017, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

Contractual Obligations and Commercial Commitments

Indemnification Agreements

In the ordinary course of business, we enter into agreements of varying scope and terms pursuant to which we agree to indemnify customers, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by us or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon us to provide indemnification under such agreements and there are no claims that we are aware of that could have a material effect on our consolidated financial position and results of operations.

Operating Leases

We lease various office and manufacturing facilities, including our corporate headquarters in Westlake Village, California, under operating lease agreements that expire through 2021. The terms of the lease agreements provide for rental payments on a graduated basis. We recognize rent expense on a straight-line basis over the lease periods.

As of June 30, 2018, our principal commitments consisted of obligations under the operating leases for our office and manufacturing facilities. The following table summarizes our future minimum payments under these arrangements:

(in thousands)

2018 2019 2020 2021 Thereafter Total
Operating Leases $167 $293 $162 $68 $0 $690

Controls and procedures

As filed, 1,993 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The phrase “disclosure controls and procedures” refers to controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended, or the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission, or SEC. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our chief executive officer, or CEO, and chief financial officer, or CFO, as appropriate to allow timely decision regarding required disclosure.

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of June 30, 2018, the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our CEO and CFO had concluded that as of June 30, 2018, our disclosure controls and procedures were designed at a reasonable assurance level and were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Controls over Financial Reporting

There was no change in our internal control over financial reporting during the period ended June 30, 2018 that materially affected, or is reasonable likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 549 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

This Quarterly Report on Form 10-Q contains forward-looking statements, which are subject to a variety of risks and uncertainties. Other actual results could differ materially from those anticipated in those forward-looking statements as a result of various factors, including those set forth in the risk factors relating to our business and common stock contained in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2017. There have been no material changes to such risk factors during the three months ended June 30, 2018.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-04-01 to 2018-06-30$2.7mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Revenue6 months2018-01-01 to 2018-06-30$5.3mus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue3 months2018-04-01 to 2018-06-30$1.1mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2018-01-01 to 2018-06-30$2.3mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2018-04-01 to 2018-06-30$1.5mus-gaap:GrossProfit
Gross profit6 months2018-01-01 to 2018-06-30$3.0mus-gaap:GrossProfit
Research and development3 months2018-04-01 to 2018-06-30$237.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$461.0kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-04-01 to 2018-06-30$881.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2018-01-01 to 2018-06-30$1.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-04-01 to 2018-06-30$430.0kus-gaap:OperatingIncomeLoss
Operating income6 months2018-01-01 to 2018-06-30$649.0kus-gaap:OperatingIncomeLoss
Income tax3 months2018-04-01 to 2018-06-30$133.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-01-01 to 2018-06-30$188.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-04-01 to 2018-06-30$359.0kus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30$477.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30$0.05us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30$0.06us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)3 months2018-04-01 to 2018-06-307,407,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2018-01-01 to 2018-06-307,410,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2018-01-01 to 2018-06-30$1.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-01-01 to 2018-06-30$202.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2018-01-01 to 2018-06-30$2.8mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2018-06-30$5.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-06-30$8.2mus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$9.4mus-gaap:Assets
Current liabilitiesAt period end2018-06-30$544.0kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-06-30$544.0kus-gaap:Liabilities
Shareholders' equityAt period end2018-06-30$8.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-18-006815. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.